Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012

In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress. Click here to download the full report Erik Miljan believes that the actual value is several fold higher, find out more at our 3 day Stem Cells …

What have Advanced Cell Technology done to succeed and progress through clinical development #stemcells #regenerativemedicine

Gary Rabin, CEO, Advanced Cell Technology explains the progress being made and the lessons learned as they commenced 2 human clinical trials using hESC-derived RPE cells for the treatment of Stargardt's Macular Dystrophy and dry AMD in this presentation delivered at the World Stem Cells & Regenerative Medicine Congress. It is often said that the best way to succeed is …